Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial.
Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, Chipman JG, Schacker TW, Guirgis FW, Voelker HT, Koopmeiners JS, Tignanelli CJ; Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. Puskarich MA, et al. Among authors: wacker da. JAMA Netw Open. 2022 Mar 1;5(3):e222735. doi: 10.1001/jamanetworkopen.2022.2735. JAMA Netw Open. 2022. PMID: 35294537 Free PMC article. Clinical Trial.
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19.
Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ. Puskarich MA, et al. Among authors: wacker da. EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34195577 Free PMC article.
The authors reply.
Reilkoff RA, Proper J, Wacker DA. Reilkoff RA, et al. Among authors: wacker da. Crit Care Med. 2022 Jun 1;50(6):e612-e613. doi: 10.1097/CCM.0000000000005544. Epub 2022 May 19. Crit Care Med. 2022. PMID: 35612460 No abstract available.
Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies.
Castro-Pearson S, Samorodnitsky S, Yang K, Lotfi-Emran S, Ingraham NE, Bramante C, Jones EK, Greising S, Yu M, Steffen B, Svensson J, Åhlberg E, Österberg B, Wacker D, Guan W, Puskarich M, Smed-Sörensen A, Lusczek E, Safo SE, Tignanelli CJ. Castro-Pearson S, et al. Sci Rep. 2023 Nov 20;13(1):20315. doi: 10.1038/s41598-023-46343-1. Sci Rep. 2023. PMID: 37985892 Free PMC article.
Shock.
Wacker DA, Winters ME. Wacker DA, et al. Emerg Med Clin North Am. 2014 Nov;32(4):747-58. doi: 10.1016/j.emc.2014.07.003. Epub 2014 Aug 28. Emerg Med Clin North Am. 2014. PMID: 25441032 Review.
35 results